Profil
Françoise Bono worked as a Senior Director-Strategic Development at OSE Immunotherapeutics SA from 2021 to 2023.
Prior to that, she was the Chief Scientific Officer at Valerio Therapeutics SA from 2017 to 2020.
She also served as the Executive Vice President-Oncology at Evotec (France) SAS in 2015 and 2016.
Dr. Bono holds a doctorate degree from Institut d'Administration Des Entreprises De Toulouse.
Anciens postes connus de Françoise Bono
| Sociétés | Poste | Fin |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Corporate Officer/Principal | 02/12/2023 |
| VALERIO THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/11/2020 |
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of physical and natural sciences | Corporate Officer/Principal | 01/11/2016 |
Formation de Françoise Bono
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Valerio Therapeutics SA
Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Institut d'Administration Des Entreprises De Toulouse
Institut d'Administration Des Entreprises De Toulouse Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of physical and natural sciences | Commercial Services |
















